Nomber.inj 🥷

@injective launched its mainnet in 2021 with a clear vision to build a blockchain specifically designed for financial applications and make onchain markets more accessible. 5 years later, that vision has expanded significantly. Injective has evolved from a blockchain focused on crypto-native markets and is now building infrastructure for regulated investment products, institutional asset issuance and real-world financial operations. Here are some of the key developments that highlight this progress: > Canary's first U.S. Staked $INJ ETF began trading on Nasdaq under ticker $INJC. > Bitnomial launched the first CFTC-regulated US $INJ futures. > Merkle Capital introduced Asia's first regulated $INJ investment fund. > $INJ gained a regulated path across Europe through Injective's MiCA whitepaper registration. > First L1 to become an SEC registered transfer agent. > Injective Mint launched in beta to enable no-code issuance with built in compliance controls. > Pentiv brought over $1B in mortgage records onchain. > POSCO International and LG CNS selected Injective for tokenizing trade receivables. > Injective is working to bring Korean won-backed payments and settlement onchain. > Circle-issued native USDC launched on Injective, with CCTP enabling crosschain transfers. > Institutional Rail introduced to connect banks directly with blockchain infrastructure. > CypherOS is being developed to make financial activities on Injective more confidential. > Injective is preparing its infrastructure for the quantum computing era with quantum resistant security. From its first block to its growing role in institutional finance, @injective has made a significant transition in just five years. And if this is what the first five years have brought, the next chapter has plenty of room to surprise us.